Ridker Paul M.; Everett Brendan M.; Thuren Tom; MacFadyen Jean G.; Chang W. H.; Ballantyne C.; Fonseca Francisco; Nicolau J.; Koenig W.; Forster Tamás; et al.; CANTOS Trial Group; Kiss Róbert Gábor; László Zoltán; Merkely Béla Péter; Sárszegi Zsolt; Benedek Imre-Sándor; et al.:
Antiinflammatory therapy with canakinumab for atherosclerotic disease.
NEW ENGLAND JOURNAL OF MEDICINE, 377 (12).
pp. 1119-1131.
ISSN 0028-4793
(2017)
Ridker Paul M.; MacFadyen Jean G.; Thuren Tom; Everett Brendan M.; Libby Peter; Glynn Robert J.; CANTOS Trial Group; Forster Tamás; Ridker Paul; Lorenzatti Alberto; Krum Henry; Varigos John; Siostrzonek Peter; Sinnaeve Peter; Fonseca Francisco; et al.:
Effect of interleukin-1 beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
LANCET, 390 (10105).
pp. 1833-1842.
ISSN 0140-6736
(2017)